Cerebral palsy is one of the most common types of childhood disabilities and one of the most complex associated with injury during the developmental mother-child period and after birth. It presents a considerable challenge for global health, with approximately three children out of every one thousand permanently affected by this disability. The lifelong consequences include motor difficulties, problems with muscle tonicity, and movement difficulties. The effects of this condition cause severe impairment of the affected child’s ability to perform daily activities, resulting in poor ability to care for oneself and poor functioning in social and community living. It causes a lifelong injury and suffering to the child and great emotional and financial stress to the family. The medical community is challenged to present effective cures for the condition and improve the quality of life of the children affected. Current techniques and research are focusing on the regenerative healing of the injured brain with cord blood stem cells. This research into UC-MSCs promises to restore the brain of the child with cerebral palsy and reduce the stress to the child and family. The development of Stem cell therapy Bangkok Thailand will further the restorative cellular techniques and provide hope to the affected children. This review provides a framework to understand the benefits of restorative cellular therapy.
Therapies for cerebral palsy revolve around supportive therapy due to the lack of available curative medical options, creating an urgent need for advances like Stem cell therapy Bangkok Thailand using UC-MSCs. The focus of rehabilitation is on the improvement of the affected motor ability, while drug therapy is used to reduce the symptoms of muscle spasms, seizures, pain, and other symptoms. Muscle releases and corrections of anatomical deformities via surgical interventions can be required. Financially, this can be a significant burden, particularly since it may require decades of continued care. As with almost all traditional methods, there is an enormous limitation with these surgical interventions. They cannot reverse the core injury of the brain. An absolute cure for cerebral palsy does not exist anywhere with the use of traditional methods. These methods only control the condition, and may bring some temporary comfort or prevent some secondary problems. The brain remains injured and the tissue remains unhealed. The lack of a definitive cure creates an absolute need for interventions that can repair tissue, stimulate neurogenesis and modulate the immune system. This creates a gap in the clinical market which is becoming an attractive area of research to explore the potential of UC-MSCs for the treatment of cerebral palsy via Stem cell therapy Bangkok Thailand.
To evaluate the potential of UC-MSCs in Stem cell therapy Bangkok Thailand for cerebral palsy, it is essential to evaluate their mechanisms at a molecular level. UC-MSCs do not promote the replacement of damaged neurons. Rather, they release an enormous amount of secretions that contain bio-active cytokines, metabolites, and exosomes. The secretions of UC-MSCs do engage with the pathogenic inflammation that is a result of the injury and becomes a chronic adaptive inflammation after brain injury. At a molecular level, these cells secrete a number of important neurotrophic factors, in particular Vasculature Endothelial Growth Factor (VEGF), Brain-Derived Neurotrophic Factor (BDNF) and Glial Cell Line Derived Neurotrophic Factor. These factors promote the growth of sperm and improve neural cell viability. UC-MSCs have the ability to directly interact with the immune system in the central nervous system. They reduce neuroinflammation in cerebral palsy through macrophage polarization towards anti-inflammatory. This prevents microglial activation and reduces damage from the cascade of T-cell responses. Through the bystander effect and cell-to-cell communication via extracellular vesicles, these UC-MSCs induce tissue regeneration throughout the body. A recent review of important discoveries shows that the removal of these stromal cells by macrophages activates prolonged and significant reductions of inflammation, showing that these cells have immunomodulatory effects. The complex activity of these cells and the absence of an immune response enable them to be used effectively as allografts without the threat of intense immune rejection in Stem cell therapy Bangkok Thailand.
There is ample clinical evidence to support that these molecular effects translate into benefits to the patients. There is an interesting case study of a four-year-old boy who was diagnosed with cerebral palsy and had symptoms of irregular seizures, an unstable gait and severe motor difficulties. This boy received three successive transplantations of UC-MSCs as part of the Stem cell therapy Bangkok Thailand treatment protocol. Following the administration of stem cells, the boy showed dramatic improvement in motor control, limb strength, and the ability to express himself verbally. EEG studies showed a generally improved and normal state. This boy also showed improvement in his gait as his heels began to make contact with the ground. A review of the clinical studies and trials showed similar results. The use of UC-MSCs shows marked, statistically significant improvements in gross motor function across diverse controlled trials for cerebral palsy. When compared to control groups, those undergoing treatment with these cellular therapies, such as Stem cell therapy Bangkok Thailand, show improvements to varying degrees with respect to self-care, mobility, and social function. These therapeutic trials confirm the empirical potential of these cellular therapies. The benefits of the therapies are accompanied by an excellent safety record. Extensive follow-up has shown no serious adverse events and only mild, transient reactions that were easily managed in the clinical setting.
Figure 1: Advancing care with UC-MSCs in cerebral palsy
The introduction of regenerative protocols to pediatric neurology is revolutionary. The rapid growth of Stem cell therapy Bangkok Thailand is establishing the area as a new focal point of cutting-edge biomedical research and the clinical application of research. Local research institutes conduct thorough investigations to optimize laboratory protocols to enhance cellular expansion and to maximize the viability of secretomes and biological activity prior to the cellular infusion. As the specialized infrastructure grows, the availability of UC-MSCs to treat cerebral palsy will significantly improve. This therapy will be most effective when the optimal methodology for administering the therapy and assessing the therapeutic effects is developed. There is research in progress that the medical community believes will soon lead to the large clinical trials that will define cellular therapies for patients with cerebral palsy. The potential of Stem cell therapy Bangkok Thailand is unprecedented. Currently the therapies are only available in Thailand. The therapies have the potential to be the first to heal the unhealable with the use of UC-MSCs.